癌症热点突变通过选择性排除对接相互作用来重新调节ERK2的特异性
Jaylissa Torres Robles1, Amy L Stiegler2, Titus J Boggon3
1Department of Chemistry, Yale University, New Haven, Connecticut, USA; Department of Pharmacology, Yale School of Medicine, New Haven, Connecticut, USA.
The Journal of biological chemistry
|February 27, 2025
概括
癌症相关的ERK2 (细胞外信号调节激酶2) 突变选择性地破坏特定蛋白质相互作用,改变其在瘤发育中的功能. 了解这些改变的相互作用,可以深入了解癌症机制.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 结构生物学 结构生物学
背景情况:
- 蛋白激酶ERK2在人类癌症中经常发生突变,特别是状细胞癌.
- 这些突变发生在关键的对接点,影响与含有短线性图案的基板和调节器的相互作用.
- 这些突变对ERK2广泛交互网络的确切影响仍然不完全理解.
研究的目的:
- 研究与癌症相关的ERK2突变如何改变其蛋白质-蛋白质相互作用格局.
- 为了确定由这些突变破坏或维持的特定分子相互作用.
- 阐明选择性相互作用破坏背后的结构机制.
主要方法:
- 酵母菌对蛋白质组短线性基因的双杂交选与野生类型 (WT) 和突变ERK2.
- 使用选择性的 WT ERK2 的共同晶体结构的确定.
- 测量ERK2激酶活性在特定基质上的生物化学测定.
主要成果:
- 大多数与WT ERK2的相互作用与突变形式保持在一起,但选择性地丢失了特定的动机相互作用.
- 结构分析揭示了关键残留物 (Glu81,Arg135,Asp321,Glu322) 的突变如何影响结合.
- 突变ERK2显示基质GEF-H1/ARHGEF2的酸化减少,该基质含有WT选择性对接图案.
结论:
- ERK2热点突变表现出特定蛋白质相互作用的选择性破坏,而不是完全失去结合.
- 结构洞察力解释了由癌症突变抑制选择性相互作用的机制.
- 改变的ERK2相互作用和激酶活性表明癌症中途径重新连接的新机制.
相关概念视频
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Mismatch Repair
4.7K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.7K
MAPK Signaling Cascades
5.1K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.1K


